Latest papers

Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson's disease.

Dopamine D2(High) receptors moderately elevated by sertindole.

Domperidone interferes with conditioned disgust reactions but not taste avoidance evoked by a LiCl-paired taste in infant rats.

Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.

Rabeprazole plus domperidone: the answer for gastro-oesophageal reflux disease.

HPTLC determination of rabeprazole and domperidone in capsules and its validation.

Quantitative determination of domperidone in human plasma by ultraperformance liquid chromatography with electrospray ionization tandem mass spectrometry.

Dosage and drug interactions of domperidone.

Dopamine D2(High) receptors on intact cells.

Effects of dopamine on ATP-sensitive potassium channels in porcine coronary artery smooth-muscle cells.

Memantine agonist action at dopamine D2High receptors.

Dopamine partial agonist actions of the glutamate receptor agonists LY 354,740 and LY 379,268.

In vitro macrophage activity: biphasic effect of prolactin and indirect evidence of dopaminergic modulation.

Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.

[Major gastrointestinal syndromes (2): dyspepsia or syndrome of the upper digestive system related with food (2)].

Role of ion channel modifiers in reversal of morphine-induced gastrointestinal inertia by prokinetic agents in mice.

Column reversed-phase high-performance liquid chromatographic method for simultaneous determination of rabeprazole sodium and domperidone in combined tablet dosage form.

Second-derivative synchronous fluorometric method for the simultaneous determination of cinnarizine and domperidone in pharmaceutical preparations. Application to biological fluids.

Review article: The diagnosis and management of gastroparesis.

Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors.